Xocova (ensitrelvir) has been approved for COVID-19 prevention in Japan on the basis of promising trial results.Credit: The Yomiuri Shimbun via AP Images/Alamy
Posted on 05/13/2026 8:33:54 PM PDT by Red Badger
An antiviral pill has, for the first time, been shown to prevent COVID-19 in people exposed to the SARS-CoV-2 virus at home, according to trial results published today in the New England Journal of Medicine1.
The drug could be a lifeline for those who still face real danger from the virus, such as care-home residents or transplant recipients on immune-suppressing medication.
The advance arrives years after the peak of the COVID-19 pandemic, so the real-world impact might be felt by only a narrow band of individuals. Still, “as a 78-year-old with comorbidities, I certainly would use it if I had a known exposure”, says study co-author Frederick Hayden, a clinical virologist at the University of Virginia School of Medicine in Charlottesville.
Antiviral antidote The drug, called ensitrelvir, is made by the Japanese pharmaceutical company Shionogi. It blocks an enzyme that coronaviruses need to make new copies of themselves, hitting the same target as one of the two active ingredients in Pfizer’s antiviral Paxlovid. But whereas that ingredient, nirmatrelvir, failed to prevent household infections in trials2, ensitrelvir has come through.
In an international study of more than 2,000 household contacts conducted from June 2023 to September 2024, about 9% of people who got a placebo within 72 hours of a housemate developing symptoms became symptomatic themselves, compared with only about 3% of those who got a five-day course of ensitrelvir. Rates of viral transmission were lower in the ensitrelvir group, too: confirmed infections, symptomatic or not, turned up in only 14.0% of those who received the drug, compared with 21.5% of those who got a placebo.
The therapy generally proved tolerable, without the taste-related side effects often seen with Paxlovid and, overall, similar toxicity as the placebo.
(Excerpt) Read more at nature.com ...
Dear FRiends,
We need your continuing support to keep FR funded. Your donations are our sole source of funding. No sugar daddies, no advertisers, no paid memberships, no commercial sales, no gimmicks, no tax subsidies. No spam, no pop-ups, no ad trackers.
If you enjoy using FR and agree it's a worthwhile endeavor, please consider making a contribution today:
Click here: to donate by Credit Card
Or here: to donate by PayPal
Or by mail to: Free Republic, LLC - PO Box 9771 - Fresno, CA 93794
Thank you very much and God bless you,
Jim
Xocova (ensitrelvir) has been approved for COVID-19 prevention in Japan on the basis of promising trial results.Credit: The Yomiuri Shimbun via AP Images/Alamy
I’m not taking that.
lets try ivermectin first , at this point i trust nobody.
Sounds like they’ve come up with a pharmaceutical strategy that could be applied to other similar viruses with a little tweaking to fit them. That would be wonderful.
What is really needed is a pill to prevent COVID-1984 after exposure to the COVID-1984 mRNA vaccine.
But..but... The vaccines!
I thought they were safe and effective?
\s
Look at the alphabet in that picture. A real “Lerning Center.”
Good eyes.
Don't you mean “Learing Center”?
I saw th egoofy alphabet when the image was generated. I could have corrected it easily but thought that it fit the situation better the way that it was.
*** The therapy generally proved tolerable, without the taste-related side effects often seen with Paxlovid***
I took Paxlovid the first time I had CoVid. Never again. That stuff was awful.
So will Ivermectin.
The journal Nature is ‘compromised’ in my book.
I’ll pass. No thank you.
#1. Those are huge tablets, real Horse Pills!
One may need to break up and pulverize first.
#2. The Painting itself. I never cease to admire and be amazed at the enormous talent of Mr. Norman Rockwell.
Most painters are either naturally good at hard line subjects, such as floorboards, furniture and letters.
While others excel in Soft or Curvilinear subjects, such as animals, people or objects found in nature.
Rockwell was an expert at both types of subject.
His results never looked overworked or labored.
He also knew a great deal about the effects of lighting, warm, cool or neutral. One of a kind!
I’ll also go with Ivermectin, but
I trust the Japanese a hell of a lot more than the USG ..
I assume you realize that I prompted Google Gemini to generate an AI image using Nano Banana in the Rockwell's style. I am a fan of this genre as well. And Gemini does what I consider a good job of creating images in his style.
I didn’t know that was a concoction of AI, but the freshness of all the colors did catch me by surprise. I figured somebody used some type of filter to refresh all the hues.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.